SCHEMBL18347659

SCHEMBL18347659

CC(C)C(=O)Nc1c(N)cc(O)c2ccccc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.48
▸ MEN1 O00255 4/20 0.46
▸ KMT2A Q03164 4/20 0.46
▸ SMN1; SMN2 Q16637 3/20 0.46
▸ GAA P10253 3/20 0.46
▸ RAB9A P51151 2/20 0.46
▸ NPC1 O15118 1/20 0.46
▸ IDO1 P14902 2/20 0.46
▸ ALDH1A1 P00352 3/20 0.44
▸ MAPT P10636 2/20 0.44
▸ RXFP1 Q9HBX9 1/20 0.44
▸ KCNJ11 Q14654 1/20 0.43
▸ LMNA P02545 2/20 0.42
▸ MAOB P27338 1/20 0.42
▸ HPGD P15428 3/20 0.42
▸ HTT P42858 1/20 0.42
▸ NPSR1 Q6W5P4 1/20 0.42
▸ CA12 O43570 1/20 0.42
▸ CA1 P00915 1/20 0.42
▸ CA2 P00918 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18347734 0.77 LMNA (0.48) KDM4EMEN1KMT2ASMN1; SMN2GAA
SCHEMBL12599079 0.71 IDO1 (0.77) MEN1KMT2AGAAIDO1ALDH1A1
SCHEMBL18347675 0.69 KDM4E (0.37) KDM4EMEN1KMT2AGAAIDO1
SCHEMBL26885028 0.69 LMNA (0.49) MEN1KMT2ASMN1; SMN2GAARAB9A
SCHEMBL6878531 0.68 MDM4 (0.65) MEN1KMT2ARAB9ANPC1ALDH1A1
SCHEMBL26885099 0.68 IDO1 (0.62) GAAIDO1ALDH1A1LMNAHPGD
SCHEMBL6655334 0.68 ATM (0.49) MEN1KMT2ASMN1; SMN2ALDH1A1MAPT
SCHEMBL7535782 0.67 GAA (0.46) KDM4EMEN1KMT2AGAANPC1
SCHEMBL26886458 0.67 LMNA (0.47) MEN1KMT2ASMN1; SMN2GAARAB9A
SCHEMBL10447471 0.66 TP53 (0.67) KDM4EMEN1KMT2AGAARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10766882-B2 1,2-naphthoquinone based derivative and method of preparing the same YUNGJIN PHARM CO., LTD. (KR) 2020-09-08 — — US disclosed
US-9975883-B2 1,2-naphthoquinone based derivative and method of preparing the same YUNGJIN PHARM. CO., LTD. (KR) 2018-05-22 — — US disclosed
US-9975883-B2 1,2-naphthoquinone based derivative and method of preparing the same YUNGJIN PHARM. CO., LTD. (KR) 2018-05-22 — — US disclosed
US-20160376258-A1 1,2-NAPHTHOQUINONE BASED DERIVATIVE AND METHOD OF PREPARING THE SAME KT&G LIFE SCIENCES CORPORATION (KR) 2016-12-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10766882-B2 1,2-naphthoquinone based derivative and method of preparing the same CYP2S1, GYS2, SLC5A1 KDM4E 3755/4885MEN1 165/4885KMT2A 3319/4885
US-20160376258-A1 1,2-NAPHTHOQUINONE BASED DERIVATIVE AND METHOD OF PREPARING THE SAME CYP2S1, GYS2, SLC5A1 KDM4E 3755/4885MEN1 165/4885KMT2A 3319/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback